<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Petrlova J</submitter><funding>NIA NIH HHS</funding><funding>U.S. National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>402-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3016465</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>79(2)</volume><pubmed_abstract>The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ∼15% of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker f</pubmed_abstract><journal>Proteins</journal><pubmed_title>A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution.</pubmed_title><pmcid>PMC3016465</pmcid><funding_grant_id>R01 AG029246-04</funding_grant_id><funding_grant_id>R01 AG029246-03</funding_grant_id><funding_grant_id>AG031362</funding_grant_id><funding_grant_id>R01 GM080542</funding_grant_id><funding_grant_id>R01 AG029246-05</funding_grant_id><funding_grant_id>AG010129</funding_grant_id><funding_grant_id>R01 AG029246-02</funding_grant_id><funding_grant_id>R01 AG029246-01A1</funding_grant_id><funding_grant_id>R01 AG029246</funding_grant_id><pubmed_authors>Hong HS</pubmed_authors><pubmed_authors>Harishchandra G</pubmed_authors><pubmed_authors>Bricarello DA</pubmed_authors><pubmed_authors>Lorigan GA</pubmed_authors><pubmed_authors>Petrlova J</pubmed_authors><pubmed_authors>Voss JC</pubmed_authors><pubmed_authors>Jin LW</pubmed_authors></additional><is_claimable>false</is_claimable><name>A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution.</name><description>The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ∼15% of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker f</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Feb</publication><modification>2025-04-04T19:18:36.356Z</modification><creation>2019-03-27T00:37:52Z</creation></dates><accession>S-EPMC3016465</accession><cross_references><pubmed>21069870</pubmed><doi>10.1002/prot.22891</doi></cross_references></HashMap>